Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients

1 Jan 2019

Abstract excerpt

Glioblastoma (GBM) is one of the lethal tumors with poor prognosis. However, prognostic prediction approaches need to be further explored. Therefore, we developed an evaluation system that could be used for prognostic prediction of GBM patients. Published mRNA expression datasets from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Chinese Glioma Genome Atlas (CGGA) were analyzed. Quantitative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Ferroptosis and cancer prognosis
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31632497
DOI: 10.7150/jca.30614

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma PatientsPMID 31632497Read ↗

Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of GlioblastomasSemantic proximity Read ↗

A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastomaSemantic proximity Read ↗

Molecular classification of IDH-mutant glioblastomas based on gene expression profilesSemantic proximity Read ↗

Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of GlioblastomaSemantic proximity Read ↗

Integrative Analysis of Dna Methylation and Gene Expression Profiles to Explore Potential Biomarkers of GlioblastomaSemantic proximity Read ↗

A Novel DNA Methylation-Based Signature Can Predict the Responses of MGMT Promoter Unmethylated Glioblastomas to TemozolomideSemantic proximity Read ↗

Identification of EMT-related gene signatures in glioblastoma to aid immunotherapy and prognosisSemantic proximity Read ↗

Potential therapeutic targets for glioblastoma patients based on a prognostic risk modelSemantic proximity Read ↗

Novel Biomarker Genes for Prognosis of Survival and Treatment of GliomaSemantic proximity Read ↗

A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastomaSemantic proximity Read ↗

Integrating Radiosensitivity Gene Signature Improves Glioma Outcome and Radiotherapy Response PredictionSemantic proximity Read ↗

Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct PrognosesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.